Literature DB >> 28373802

Is the Ultimate Treatment Response Predictable with Early Response in Major Depressive Episode?

Aslı Çiftçi1, Halis Ulaş2, Ahmet Topuzoğlu2, Zeliha Tunca3.   

Abstract

INTRODUCTION: New evidence suggests that the efficacy of antidepressants occurs within the first weeks of treatment and this early response predicts the later response. The purpose of the present study was to investigate if the partial response in the first week predicts the response at the end of treatment in patients with major depressive disorder who are treated with either antidepressant medication or electroconvulsive therapy.
METHODS: Inpatients from Dokuz Eylül University Hospital with a major depressive episode, treated with antidepressant medication (n=52) or electroconvulsive therapy (ECT) (n=48), were recruited for the study. The data were retrospectively collected to decide whether a 25% decrease in the Hamilton Depression Rating Scale (HDRS) score at the first week of treatment predicts a 50% decrease at the third week using validity analysis. In addition, the effects of socio-demographic and clinical variables on the treatment response were assessed.
RESULTS: A 25% decrease in the HDRS score in the first week of treatment predicted a 50% decrease in the HDRS score in the third week with a 78.3% positive predictive value, 62.1% negative predictive value, 62.1% sensitivity, and 78.3% specificity for antidepressant medications and an 88% positive predictive value, 52.2% negative predictive value, 66.7% sensitivity, and 80% specificity for ECT. The number of previous hospitalizations, comorbid medical illnesses, number of depressive episodes, duration of illness, and duration of the current episode were related to the treatment response.
CONCLUSION: Treatment response in the first week predicted the response in the third week with a high specificity and a high positive predictive value. Close monitoring of the response from the first week of treatment may thus help the clinician to predict the subsequent response.

Entities:  

Keywords:  Antidepressant medications; electroconvulsive therapy; major depressive disorder; prediction; response

Year:  2016        PMID: 28373802      PMCID: PMC5378219          DOI: 10.5152/npa.2015.10141

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  25 in total

1.  [Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population].

Authors:  Can Güngen; Turan Ertan; Engin Eker; Resmiye Yaşar; Funda Engin
Journal:  Turk Psikiyatri Derg       Date:  2002

2.  Prediction of response to ECT with routinely collected data in major depression.

Authors:  Iris M de Vreede; Huibert Burger; Irene M van Vliet
Journal:  J Affect Disord       Date:  2005-06       Impact factor: 4.839

3.  A practical approach to the early identification of antidepressant medication non-responders.

Authors:  J Li; A Y C Kuk; A J Rush
Journal:  Psychol Med       Date:  2011-07-25       Impact factor: 7.723

Review 4.  Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.

Authors:  Matthew J Taylor; Nick Freemantle; John R Geddes; Zubin Bhagwagar
Journal:  Arch Gen Psychiatry       Date:  2006-11

5.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

6.  What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.

Authors:  Bradley N Gaynes; Diane Warden; Madhukar H Trivedi; Stephen R Wisniewski; Maurizio Fava; A John Rush
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

7.  Outcomes of 1014 naturalistically treated inpatients with major depressive episode.

Authors:  Florian Seemüller; Michael Riedel; Michael Obermeier; Michael Bauer; Mazda Adli; Klaus Kronmüller; Florian Holsboer; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Eva Dichgans; Roland Bottländer; Richard Musil; Hans-Jürgen Möller
Journal:  Eur Neuropsychopharmacol       Date:  2010-01-22       Impact factor: 4.600

8.  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

Authors:  Raymond W Lam; Sidney H Kennedy; Sophie Grigoriadis; Roger S McIntyre; Roumen Milev; Rajamannar Ramasubbu; Sagar V Parikh; Scott B Patten; Arun V Ravindran
Journal:  J Affect Disord       Date:  2009-08-11       Impact factor: 4.839

9.  Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.

Authors:  Martin M Katz; Janet L Tekell; Charles L Bowden; Steve Brannan; John P Houston; Nancy Berman; Alan Frazer
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

Review 10.  Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

Authors:  Norio Watanabe; Ichiro M Omori; Atsuo Nakagawa; Andrea Cipriani; Corrado Barbui; Hugh McGuire; Rachel Churchill; Toshiaki A Furukawa
Journal:  J Clin Psychiatry       Date:  2008-09       Impact factor: 4.384

View more
  2 in total

1.  Predictability of Nonremitting Depression After First 2 Weeks of Antidepressant Treatment: A VAST-D Trial Report.

Authors:  Paul B Hicks; Varadan Sevilimedu; Gary R Johnson; Ilanit Tal; Peijun Chen; Lori L Davis; Julia E Vertrees; Somaia Mohamed; Sidney Zisook
Journal:  Psychiatr Res Clin Pract       Date:  2019-10-03

2.  Cognitive remediation following electroconvulsive therapy in patients with treatment resistant depression: randomized controlled trail of an intervention for relapse prevention - study protocol.

Authors:  Nele Van de Velde; Mitchel Kappen; Ernst H W Koster; Kristof Hoorelbeke; Hannelore Tandt; Pieter Verslype; Chris Baeken; Rudi De Raedt; Gilbert Lemmens; Marie-Anne Vanderhasselt
Journal:  BMC Psychiatry       Date:  2020-09-16       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.